Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest Intraocular pressure Stories

2012-03-13 01:30:00

SOPHIA ANTIPOLIS, France and MADISON, N.J., March 13, 2012 /PRNewswire/ -- Bausch + Lomb, the global eye health company, and NicOx S.A. (NYSE Euronext Paris: COX) today announced positive top-line results from the phase 2b study conducted with BOL?303259?X, a novel nitric oxide-donating prostaglandin F2?alpha analog, in patients with open-angle glaucoma or ocular hypertension. BOL?303259?X (previously NCX 116) was licensed by NicOx to Bausch + Lomb in March 2010 (see NicOx and Bausch...

2012-03-07 13:51:11

Measurement of pressure within the eye, or intraocular pressure (IOP), is known to fluctuate throughout the day, and wide swings in patients with glaucoma are believed to be related to the progression of the disease, which can cause permanent damage to the optic nerve and vision. The clinical assessment of IOP, however, has been restricted to office visits during daytime hours. In a new study, parents using the Icare Rebound Tonometer evaluated IOP patterns in normal children at home,...

2012-03-07 13:49:33

A new paradigm to explain glaucoma is rapidly emerging, and it is generating brain-based treatment advances that may ultimately vanquish the disease known as the "sneak thief of sight." A review now available in Ophthalmology, the journal of the American Academy of Ophthalmology, reports that some top researchers no longer think of glaucoma solely as an eye disease. Instead, they view it as a neurologic disorder that causes nerve cells in the brain to degenerate and die, similar to what...

2012-01-17 22:54:38

Glaucoma is the second leading cause of blindness. Nearly 4 million Americans have the disorder, which affects 70 million worldwide. There is no cure and no early symptoms. Once vision is lost, it´s permanent. New findings at Georgia Tech, published in January during Glaucoma Awareness Month, explore one of the many molecular origins of glaucoma and advance research dedicated to fighting the disease. Glaucoma is typically triggered when fluid is unable to circulate freely through...

2012-01-05 11:48:44

Glaucoma is a major cause of vision loss in the United States, affecting about 2.2 million Americans. The National Eye Institute (NEI) leads research toward better prevention, detection, and treatment of this often silent but devastating disease. During Glaucoma Awareness Month, NEI highlights research advances, showcases education and awareness efforts, and reminds Americans that early detection and treatment is the best way to prevent vision loss. NEI advises all Americans at risk of...

2011-12-29 12:07:00

BARDONIA, N.Y., Dec. 29, 2011 /PRNewswire/ -- Rockland Eye Physicians, a New York leading eye physician and eye surgical clinic, is joining forces with the Glaucoma Research Foundation this January to spread the word about Glaucoma Awareness Month. Affecting over 2.2 million Americans, glaucoma is a group of dangerous eye diseases capable of robbing sight with little or no warning. Though glaucoma cannot be prevented, the key to preserving sight is in the early detection and treatment of this...

2011-12-21 11:50:00

Toxic Anterior Segment Syndrome (TASS) is a rare but sight threatening complication of cataract surgery. It occurs mainly within 48 hours after the Surgery. (PRWEB) December 21, 2011 Online Eye Info. The American Academy of Ophthalmology announced today a partnership with the U.S. Food and Drug Administration on a program to track Toxic Anterior Segment Syndrome (TASS) which is a rare but sight threatening complication of cataract surgery . The Academy will help to create an online...

How Does Space Flight Impact Astronauts' Eyes And Vision?
2011-11-03 13:30:20

Report featured in Ophthalmology, the journal of the American Academy of Ophthalmology A new study sponsored by NASA finds that space flights lasting six months or more can cause a spectrum of changes in astronauts' visual systems. Some problems, including blurry vision, appear to persist long after astronauts' return to Earth. The results are affecting plans for long-duration manned space voyages, such as a trip to Mars. The study team included ophthalmologists Thomas H. Mader, MD, of...

2011-10-31 02:00:00

OXFORD, England, October 31, 2011 /PRNewswire/ -- - Research and development agreement signed with Mayo Clinic - Oxford BioMedica plc ("Oxford BioMedica" or "the Company") (LSE: OXB), the leading gene-based biopharmaceutical company, today announces that it has entered into a research and development collaboration with Mayo Clinic, Rochester (USA) to develop a novel gene therapy for the treatment of chronic glaucoma. Under the terms of the agreement, Mayo Clinic and...

Physical Fitness Could Have Positive Impact On Eye Health
2011-10-25 03:11:39

New study links active lifestyle to reduced risk of glaucoma Physical activity may be what the doctor orders to help patients reduce their risk of developing glaucoma. According to a recently published scientific paper, higher levels of physical exercise appear to have a long-term beneficial impact on low ocular perfusion pressure (OPP), an important risk factor for glaucoma. Published in the Investigative Ophthalmology & Visual Science journal (Physical Activity and Ocular...